Cargando…
Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma
Extraskeletal myxoid chondrosarcoma (EMC) is an extremely rare soft tissue sarcoma, marked by a translocation involving the NR4A3 gene. EMC is usually indolent and moderately sensitive to anthracycline-based chemotherapy. Recently, we reported on the therapeutic activity of sunitinib in a series of...
Autores principales: | Urbini, Milena, Indio, Valentina, Astolfi, Annalisa, Tarantino, Giuseppe, Renne, Salvatore Lorenzo, Pilotti, Silvana, Dei Tos, Angelo Paolo, Maestro, Roberta, Collini, Paola, Nannini, Margherita, Saponara, Maristella, Murrone, Ludovica, Dagrada, Gian Paolo, Colombo, Chiara, Gronchi, Alessandro, Pession, Andrea, Casali, Paolo Giovanni, Stacchiotti, Silvia, Pantaleo, Maria Abbondanza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073125/ https://www.ncbi.nlm.nih.gov/pubmed/29937513 http://dx.doi.org/10.3390/ijms19071855 |
Ejemplares similares
-
Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib
por: Stacchiotti, Silvia, et al.
Publicado: (2012) -
Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study
por: Stacchiotti, Silvia, et al.
Publicado: (2013) -
Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue
por: Urbini, Milena, et al.
Publicado: (2017) -
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas
por: Brenca, Monica, et al.
Publicado: (2019) -
Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management
por: Stacchiotti, Silvia, et al.
Publicado: (2020)